샘플 요청 목록

 카트 문의
시장보고서
상품코드
1765259

세계의 기질 혈관 분획 시장

Stromal Vascular Fraction
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 214 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

기질 혈관 분획 세계 시장은 2030년까지 1억 2,780만 달러에 달할 전망

2024년에 9,820만 달러로 추정되는 기질 혈관 분획 세계 시장은 2024년부터 2030년까지 CAGR 4.5%로 성장하여 2030년에는 1억 2,780만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 분리 제품은 CAGR 4.3%를 기록하며 분석 기간 종료시에는 9,950만 달러에 달할 것으로 예측됩니다. 흡인 제품 부문의 성장률은 분석 기간 동안 CAGR 5.2%로 추정됩니다.

미국 시장은 3,230만 달러로 추정, 중국은 CAGR 5.6%로 성장 예측

미국의 기질 혈관 분획 시장은 2024년에 3,230만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 5.6%로 2030년까지 예측 시장 규모 970만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.7%와 4.0%로 예측됩니다. 유럽에서는 독일이 CAGR 4.3%로 성장할 것으로 예측됩니다.

세계의 기질 혈관 분획 시장 - 주요 동향과 촉진요인 정리

기질 혈관 분획(SVF)은 지방흡입술로 채취한 지방조직 유래의 다양한 세포 집단으로, 지방유래 줄기세포(ADSC), 내피(혈관)세포, 면역세포, 기타 세포 성분 등 여러 종류의 세포가 풍부하게 혼합되어 있습니다. SVF를 분리하는 과정에서 지방조직을 효소로 소화한 후 원심분리하여 지방세포(지방세포)에서 세포 분획을 분리하고, SVF는 현재 연부조직의 회복을 촉진하는 미용 시술부터 만성창상 치료까지 다양한 분야에서 활용되고 있습니다. 연부조직의 회복을 촉진하는 미용 시술부터 만성 상처, 골관절염, 심혈관질환의 치료와 같은 보다 복잡한 임상 시나리오에 이르기까지 다양한 치료에의 적용이 검토되고 있습니다.

SVF의 임상 치료 잠재력은 최소침습적 추출 과정과 세포 재생 능력으로 인해 엄청난 잠재력을 가지고 있으며, SVF에 대한 연구가 크게 확대되어 치유 과정을 강화하고 염증을 감소시키는 데 있어 유망한 결과를 보여주고 있습니다. 거부반응이나 유해한 면역반응의 위험을 최소화하여 다른 이식 가능한 재료에 비해 큰 이점을 제공합니다. 이 분야의 최근 발전은 SVF 내 세포의 수율과 생존율을 높이기 위한 분리 기술의 개선과 SVF 내 다양한 세포 유형의 특이적 역할에 대한 이해의 증진에 있습니다. 이러한 개선은 재생의료에서 SVF의 치료 가능성을 극대화하는 데 매우 중요하며, 현재 진행 중인 과학 연구의 주요 분야입니다.

SVF 시장의 성장은 세포 분리 기술의 발전과 재생의료에 대한 이해의 증가 등 여러 요인에 의해 주도되고 있습니다. 생명공학 연구에 대한 투자 증가는 SVF 기반 치료의 광범위한 채택에 필수적인 보다 효율적이고 확장 가능한 처리 기술의 개발을 촉진하고 있습니다. 또한, 최소침습적 미용 및 치료 시술에 대한 수요 증가는 SVF의 보급에 크게 기여하고 있습니다. 미용 및 재건 치료에 대한 수요는 젊어 보이고 젊음을 유지하려는 사람들의 끊임없는 열망으로 인해 계속 증가하고 있으며, 이는 기질 혈관 분획(SVF) 치료법과 같은 관련 시장에 충분한 기회를 창출하고 있습니다. 규제 프레임워크 또한 이러한 혁신적인 치료법의 임상적 사용에 대응할 수 있도록 진화하고 있으며, 이는 임상시험 및 적용을 촉진하고 있습니다. 또한, 일반 인구의 고령화와 함께 SVF로 치료할 수 있는 퇴행성 질환의 유병률이 증가함에 따라 대상 환자군이 확대되고 있습니다. 이러한 요소들이 복합적으로 작용하여 바이오메디컬 분야에서 SVF 분야의 지속적인 성장과 발전을 촉진하는 중요한 원동력이 되고 있습니다.

부문

제품 유형(분리 제품, 흡인 제품, 이식 제품), 용도(연조직, 미용, 정형외과, 기타 용도), 최종 용도(병원, 전문 클리닉, 줄기세포은행/연구소, 기타 최종 용도)

조사 대상 기업 사례

  • GE HealthCare PLC
  • Kyocera Corporation
  • Stempeutics Research Pvt., Ltd.
  • Genesis Biosystems, Inc.
  • IntelliCell BioSciences, Inc.
  • human med AG
  • InGeneron, Inc.
  • iXCells Biotechnologies
  • Jointechlabs, Inc.
  • Froceth
  • GID BIO
  • Obatala Sciences

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 세계 시장 개요
  • 파이프라인 분석
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.07.15

Global Stromal Vascular Fraction Market to Reach US$127.8 Million by 2030

The global market for Stromal Vascular Fraction estimated at US$98.2 Million in the year 2024, is expected to reach US$127.8 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Isolation Products, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$99.5 Million by the end of the analysis period. Growth in the Aspiration Products segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.3 Million While China is Forecast to Grow at 5.6% CAGR

The Stromal Vascular Fraction market in the U.S. is estimated at US$32.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.7 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Stromal Vascular Fraction Market - Key Trends and Drivers Summarized

Stromal Vascular Fraction (SVF) is a diverse cell population derived from adipose (fat) tissue, which is harvested through liposuction procedures. SVF contains a rich mix of several cell types including adipose-derived stem cells (ADSCs), endothelial (blood vessel) cells, immune cells, and other cellular components. This cell mixture is particularly noted for its regenerative properties, making it a promising tool in regenerative medicine and tissue engineering. The process of isolating SVF involves enzymatic digestion of adipose tissue followed by centrifugation to separate the cellular fraction from adipocytes (fat cells). SVF is currently being explored in a variety of therapeutic applications ranging from cosmetic procedures enhancing soft tissue repair to more complex clinical scenarios like treating chronic wounds, osteoarthritis, and cardiovascular diseases.

The potential of SVF in clinical therapies is vast due to its minimally invasive extraction process and the regenerative capabilities of the cells it contains. Research in SVF has expanded significantly, showing promising results in enhancing healing processes and reducing inflammation. The autologous nature of SVF (derived from the patient’s own body) minimizes the risk of rejection and adverse immune reactions, a significant advantage over other transplantable materials. Recent advancements in the field have aimed at refining the isolation techniques to increase the yield and viability of cells in SVF, and enhancing the understanding of the specific roles of different cell types within the fraction. These improvements are critical in maximizing the therapeutic potential of SVF in regenerative medicine, making it a key area of ongoing scientific research.

The growth in the SVF market is driven by several factors, including advancements in cell isolation technologies and a deepening understanding of regenerative medicine. Increased investment in biotechnology research has propelled the development of more efficient and scalable processing techniques, which are crucial for the wider adoption of SVF-based therapies. Additionally, the growing demand for minimally invasive cosmetic and therapeutic procedures has significantly contributed to the popularity of SVF. The demand for aesthetic & reconstructive therapies continues to grow owing to the never-ending desire of people to look younger and retain youthful appearance, while creating ample opportunities for related markets such as stromal vascular fraction (SVF) treatment method. Regulatory frameworks are also evolving to better accommodate the clinical use of such innovative therapies, thereby encouraging more clinical trials and applications. Moreover, as the general population ages, there is an increasing prevalence of degenerative diseases which can potentially be treated with SVF, thus expanding the target demographic. Together, these elements are key drivers promoting the sustained growth and development of the SVF sector in the biomedical field.

SCOPE OF STUDY:

The report analyzes the Stromal Vascular Fraction market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Isolation Products, Aspiration Products, Transfer Products); Application (Soft Tissue, Cosmetic, Orthopedic, Other Applications); End-Use (Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 25 Featured) -

  • GE HealthCare PLC
  • Kyocera Corporation
  • Stempeutics Research Pvt., Ltd.
  • Genesis Biosystems, Inc.
  • IntelliCell BioSciences, Inc.
  • human med AG
  • InGeneron, Inc.
  • iXCells Biotechnologies
  • Jointechlabs, Inc.
  • Froceth
  • GID BIO
  • Obatala Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Stromal Vascular Fraction - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Stem Cells, Application Areas, and the Different Types: A Prelude
    • Applications of Stem Cells
    • Types of Stem Cells
    • Stromal Vascular Fraction: An Introduction
    • Production Method for SVF
    • SVF Cell Procedure
    • SVF Composition, Content, and Source
    • SVF: Mechanism of Action
    • SVF: Clinical Applications
    • Safety and Efficiency of SVF
    • Clinical Trials and Regulations Related to SVF
    • Limitations and Scope
  • GLOBAL MARKET OVERVIEW
    • Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
    • Soft Tissue Segment Leads the Market
    • North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
    • Lucrative Opportunities & Restraints
    • Market Restraints
    • Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
    • Extensive Application Scope
    • Rising Focus on Non-Enzymatic Isolation Techniques
    • Strong Research Focus on Optimization of Tissue Recovery
    • Consistent Efforts to Develop Better Cell Therapies
    • Competition
    • Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
    • Recent Market Activity
    • SVF Isolation Products Continue to Make Gains
  • PIPELINE ANALYSIS
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
    • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    • Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
    • Use of SVF in Osteoarthritis Treatment
    • Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
    • Increasing Awareness about Stem Cell Therapy Augurs Well
    • Innovative Methods Become Relevant in Optimizing Tissue Recovery
    • Stromal Vascular Formation Holds Significance for Chronic Diseases
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Stromal Vascular Fraction in Diabetic Care
    • Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
    • SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
    • Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
    • The Counterview
    • Contrast with Regulatory Framework Covering HCT/Ps
    • Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • High Incidence of Neurological Disorders: A Key Market Driver
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
    • Expansion of Private Hospitals in Rural Areas
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Isolation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Isolation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Aspiration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Aspiration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transfer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Transfer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Soft Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Cosmetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Cosmetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stem Cell Banks/Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Stem Cell Banks/Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Stromal Vascular Fraction Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제